Article
A genome-wide association study of myasthenia gravis.
JAMA neurology - 1 Apr 2015
Renton Alan E, Pliner Hannah A, Provenzano Carlo, Evoli Amelia, Ricciardi Roberta, Nalls Michael A, Marangi Giuseppe, Abramzon Yevgeniya, Arepalli Sampath, Chong Sean, Hernandez Dena G, Johnson Janel O, Bartoccioni Emanuela, Scuderi Flavia, Maestri Michelangelo, Gibbs J Raphael, Errichiello Edoardo, Chiò Adriano, Restagno Gabriella, Sabatelli Mario, Macek Mark, Scholz Sonja W, Corse Andrea, Chaudhry Vinay, Benatar Michael, Barohn Richard J, McVey April, Pasnoor Mamatha, Dimachkie Mazen M, Rowin Julie, Kissel John, Freimer Miriam, Kaminski Henry J, Sanders Donald B, Lipscomb Bernadette, Massey Janice M, Chopra Manisha, Howard James F, Koopman Wilma J, Nicolle Michael W, Pascuzzi Robert M, Pestronk Alan, Wulf Charlie, Florence Julaine, Blackmore Derrick, Soloway Aimee, Siddiqi Zaeem, Muppidi Srikanth, Wolfe Gil, Richman David, Mezei Michelle M, Jiwa Theresa, Oger Joel, Drachman Daniel B, Traynor Bryan J
Abstract excerpt
IMPORTANCE: Myasthenia gravis is a chronic, autoimmune, neuromuscular disease characterized by fluctuating weakness of voluntary muscle groups. Although genetic factors are known to play a role in this neuroimmunological condition, the genetic etiology underlying myasthenia gravis is not well understood. OBJECTIVE: To identify genetic variants that alter susceptibility to myasthenia gravis, we performed a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.